Skip to content

Impact of Education Methods on HPV Knowledge and Screening Behavior

The Effect of Two Different Health Education Methods on Women's HPV Knowledge, Cervical Cancer Health Belief and Screening Programme.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07017387
Enrollment
90
Registered
2025-06-12
Start date
2025-05-09
Completion date
2025-09-20
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Education, Motivational Interviewing

Keywords

cervical cancer, motivational interviewing, health education, HPV

Brief summary

The aim of this study is to evaluate the effect of two different health education methods (one based on motivational interviewing) on women's HPV knowledge, cervical cancer health beliefs, and screening behaviors in women aged 30-65. A total of 90 healthy women who are registered at the Incirli Family Health Center in Ankara, meet the inclusion criteria, and volunteer to participate will be randomly assigned to three groups (30 participants per group). The control group will receive standard healthcare services. The first intervention group will receive three sessions of motivational interviewing-based health education on cervical cancer prevention through home visits, along with an informational brochure. The second intervention group will receive health education and a brochure, followed by a reminder session via phone. At the end of the study, participants in the control group will be offered the intervention of their choice.

Detailed description

This study aims to evaluate the effect of two different health education methods-one based on motivational interviewing-on HPV knowledge, cervical cancer health beliefs, and screening behavior in women aged 30-65. A total of 90 healthy women, registered at the Incirli Family Health Center in Ankara, who meet the inclusion criteria and provide informed consent, will be randomly assigned into three groups of 30 participants each. The control group will receive standard healthcare services. The first intervention group will receive three face-to-face educational sessions based on motivational interviewing principles on HPV and cervical cancer prevention through home visits, along with an informational brochure. These sessions will occur during Weeks 1, 2, and 3. A final follow-up session to administer FORM II will be held in Week 8. The second intervention group will receive a single face-to-face educational session on HPV and cervical cancer prevention (Week 1), receive a brochure, and two follow-up reminder sessions via telephone in Weeks 2 and 3. FORM II will be administered in Week 8. After the study period, participants in the control group will be offered the opportunity to choose and receive one of the two intervention methods. All participants will complete the HPV Knowledge Scale, the Cervical Cancer and Pap Smear Test Health Belief Model Scale, and a VAS for self-assessment.

Interventions

BEHAVIORALMotivational interviewing based health education

Participants will receive three sessions of face-to-face health education using motivational interviewing techniques through home visits, along with an informational brochure.

BEHAVIORALHealth education

Participants will receive one face-to-face health education session and a brochure, followed by two reminder sessions via phone.

Sponsors

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Being between 30 and 65 years of age * Being literate * Agreeing to participate in the study * Being female * Being married * Having no history of cervical cancer in first-degree relatives (mother/sister) * Not having undergone cervical cancer screening in the last five years * Not having been diagnosed with cancer

Exclusion criteria

* Being pregnant or in the postpartum period * Having been diagnosed with any type of cancer * Having a hearing or speech impairment, or a mental disorder * Using medication due to psychotic treatments * Having undergone a hysterectomy * Having had cervical cancer screening within the last five years * Having received all three doses of the HPV vaccine

Design outcomes

Primary

MeasureTime frameDescription
Change in screening behavior8 weeks after interventionBinary outcome (Yes/No) capturing whether the participant underwent screening during the follow-up period. If Yes, the result is recorded; if No, the reason for non-participation is documented.

Secondary

MeasureTime frameDescription
Change in HPV Knowledge Score Measured by the 33-item HPV Knowledge Scale8 weeks after interventionDescription: The 33-item HPV Knowledge Scale (Demir \& Özdemir, 2019) assesses knowledge of HPV infection, screening, and vaccination. Each item is answered Yes/No/Don't know and scored 1 (for correct) or 0 (for incorrect/unknown). Total scores range 0-33; higher scores indicate greater knowledge.
Change in Health Belief About Cervical Cancer and Pap Smear as Measured by the Cervical Cancer and Pap Smear Health Belief Model Scale (35 items)8 weeks after interventionThe 35-item scale (Güvenç et al., 2011) has five subscales: Benefits \& Motivation (8 items), Barriers (14), Perceived Severity (7), Perceived Susceptibility (3), Health Motivation (3). Responses use a 5-point Likert scale (1 = Strongly disagree to 5 = Strongly agree). Subscale scores are summed; higher scores reflect stronger beliefs, except Barriers, where higher scores indicate more perceived barriers.
Change in Self-Rated Knowledge About Cervical Cancer and Screening Assessed by a 0-10 Visual Analog Scale (VAS)8 weeks after interventionDescription: Participants rate their knowledge on a 10-cm VAS anchored at 0 ("No knowledge") and 10 ("Completely knowledgeable").
Satisfaction8 weeks after interventionSatisfaction with standard care, health education, or MI-based health education assessed by VAS at 8 weeks

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026